These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
653 related articles for article (PubMed ID: 12653137)
21. Does host complement kill Borrelia burgdorferi within ticks? Rathinavelu S; Broadwater A; de Silva AM Infect Immun; 2003 Feb; 71(2):822-9. PubMed ID: 12540562 [TBL] [Abstract][Full Text] [Related]
22. Associations between Ixodes scapularis ticks and small mammal hosts in a newly endemic zone in southeastern Canada: implications for Borrelia burgdorferi transmission. Bouchard C; Beauchamp G; Nguon S; Trudel L; Milord F; Lindsay LR; Bélanger D; Ogden NH Ticks Tick Borne Dis; 2011 Dec; 2(4):183-90. PubMed ID: 22108010 [TBL] [Abstract][Full Text] [Related]
23. Interaction and transmission of two Borrelia burgdorferi sensu stricto strains in a tick-rodent maintenance system. Derdáková M; Dudiòák V; Brei B; Brownstein JS; Schwartz I; Fish D Appl Environ Microbiol; 2004 Nov; 70(11):6783-8. PubMed ID: 15528545 [TBL] [Abstract][Full Text] [Related]
24. Vector seasonality, host infection dynamics and fitness of pathogens transmitted by the tick Ixodes scapularis. Ogden NH; Bigras-Poulin M; O'callaghan CJ; Barker IK; Kurtenbach K; Lindsay LR; Charron DF Parasitology; 2007 Feb; 134(Pt 2):209-27. PubMed ID: 17032476 [TBL] [Abstract][Full Text] [Related]
25. Temporal changes in outer surface proteins A and C of the lyme disease-associated spirochete, Borrelia burgdorferi, during the chain of infection in ticks and mice. Schwan TG; Piesman J J Clin Microbiol; 2000 Jan; 38(1):382-8. PubMed ID: 10618120 [TBL] [Abstract][Full Text] [Related]
26. Interference between the agents of Lyme disease and human granulocytic ehrlichiosis in a natural reservoir host. Levin ML; Fish D Vector Borne Zoonotic Dis; 2001; 1(2):139-48. PubMed ID: 12653144 [TBL] [Abstract][Full Text] [Related]
27. Efficacy of a nonadjuvanted, outer surface protein A, recombinant vaccine in dogs after challenge by ticks naturally infected with Borrelia burgdorferi. Conlon JA; Mather TN; Tanner P; Gallo G; Jacobson RH Vet Ther; 2000; 1(2):96-107. PubMed ID: 19757556 [TBL] [Abstract][Full Text] [Related]
28. Borrelia burgdorferi infection in a natural population of Peromyscus Leucopus mice: a longitudinal study in an area where Lyme Borreliosis is highly endemic. Bunikis J; Tsao J; Luke CJ; Luna MG; Fish D; Barbour AG J Infect Dis; 2004 Apr; 189(8):1515-23. PubMed ID: 15073690 [TBL] [Abstract][Full Text] [Related]
29. Recombinant OspA protects dogs against infection and disease caused by Borrelia burgdorferi. Chang YF; Appel MJ; Jacobson RH; Shin SJ; Harpending P; Straubinger R; Patrican LA; Mohammed H; Summers BA Infect Immun; 1995 Sep; 63(9):3543-9. PubMed ID: 7642289 [TBL] [Abstract][Full Text] [Related]
30. Resistance to tick-borne spirochete challenge induced by Borrelia burgdorferi strains that differ in expression of outer surface proteins. Kurtti TJ; Munderloh UG; Hughes CA; Engstrom SM; Johnson RC Infect Immun; 1996 Oct; 64(10):4148-53. PubMed ID: 8926082 [TBL] [Abstract][Full Text] [Related]
31. Immunization of mice by recombinant OspA preparations and protection against Borrelia burgdorferi infection induced by Ixodes ricinus tick bites. Gern L; Rais O; Capiau C; Hauser P; Lobet Y; Simoen E; Voet P; Pêtre J Immunol Lett; 1994 Mar; 39(3):249-58. PubMed ID: 8034340 [TBL] [Abstract][Full Text] [Related]
32. Immunization with a polyvalent OspA vaccine protects mice against Ixodes ricinus tick bites infected by Borrelia burgdorferi ss, Borrelia garinii and Borrelia afzelii. Gern L; Hu CM; Voet P; Hauser P; Lobet Y Vaccine; 1997 Oct; 15(14):1551-7. PubMed ID: 9330467 [TBL] [Abstract][Full Text] [Related]
33. Comparative reservoir competence of Bourgeois JS; You SS; Clendenen LH; Shrestha M; Petnicki-Ocwieja T; Telford SR; Hu LT Appl Environ Microbiol; 2024 Jul; 90(7):e0082224. PubMed ID: 38899883 [No Abstract] [Full Text] [Related]
34. A fluorescent bead-based multiplex assay for the simultaneous detection of antibodies to B. burgdorferi outer surface proteins in canine serum. Wagner B; Freer H; Rollins A; Erb HN Vet Immunol Immunopathol; 2011 Apr; 140(3-4):190-8. PubMed ID: 21208663 [TBL] [Abstract][Full Text] [Related]
35. The Lyme disease vaccine candidate outer surface protein A (OspA) in a formulation compatible with human use protects mice against natural tick transmission of B. burgdorferi. Golde WT; Burkot TR; Piesman J; Dolan MC; Capiau C; Hauser P; Dequesne G; Lobet Y Vaccine; 1995 Apr; 13(5):435-41. PubMed ID: 7639011 [TBL] [Abstract][Full Text] [Related]
36. Reservoir competence of white-footed mice for Lyme disease spirochetes. Donahue JG; Piesman J; Spielman A Am J Trop Med Hyg; 1987 Jan; 36(1):92-6. PubMed ID: 3812887 [TBL] [Abstract][Full Text] [Related]
37. Characterization of recombinant OspA in two different Borrelia vaccines with respect to immunological response and its relationship to functional parameters. Grosenbaugh DA; De Luca K; Durand PY; Feilmeier B; DeWitt K; Sigoillot-Claude C; Sajous ML; Day MJ; David F BMC Vet Res; 2018 Oct; 14(1):312. PubMed ID: 30326885 [TBL] [Abstract][Full Text] [Related]
38. Borrelia burgdorferi population kinetics and selected gene expression at the host-vector interface. Hodzic E; Feng S; Freet KJ; Borjesson DL; Barthold SW Infect Immun; 2002 Jul; 70(7):3382-8. PubMed ID: 12065476 [TBL] [Abstract][Full Text] [Related]
39. Demonstration of the ability of a canine Lyme vaccine to reduce the incidence of histological synovial lesions following experimentally-induced canine Lyme borreliosis. Grosenbaugh DA; Rissi DR; Krimer PM Vet Immunol Immunopathol; 2016 Nov; 180():29-33. PubMed ID: 27692092 [TBL] [Abstract][Full Text] [Related]
40. Reservoir targeted vaccine against Borrelia burgdorferi: a new strategy to prevent Lyme disease transmission. Richer LM; Brisson D; Melo R; Ostfeld RS; Zeidner N; Gomes-Solecki M J Infect Dis; 2014 Jun; 209(12):1972-80. PubMed ID: 24523510 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]